Topics

LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday. The decision was expected after European regulators endorsed the treatment in July. J&J's Janssen unit has European rights for the product. Zytiga, or abiraterone, works by blocking the synthesis of testosterone, which can fuel cancer growth. Abiraterone was developed by researchers at the Institute of Cancer Research and London's Royal Marsden Hospital, and British pharmaceutical firm BTG will receive an undisclosed milestone payment...

Related "Johnson & Johnson Inc." Articles

LONDON (Reuters) - Johnson & Johnson's prostate cancer drug Zytiga has been approved in the European Union, paving the way for the launch of a new treatment for men whose disease has progressed after chemotherapy, the company said on Wednesday.
The...

Night driving entails a whole host of challenges, not the least of which is the frequency with which that same sappy love song pops up on station after station.
Lovelorn call-in shows aside, driving in the dark poses very real dangers to your physical...

(Reuters) - Johnson & Johnson has told doctors it expects a limited supply of its Doxil cancer drug to become available within the next six weeks, but warned the amount would not be sufficient for all patients currently on waiting lists.
Supplies...

Sunscreen is commonly hailed as safe, essential body armor. It protects us from blistering sunburn, keeps our skin from wrinkling and helps guard against squamous cell cancer.
But the evidence is inconclusive as to whether sunscreens reduce the risk of...

British scientists have found the first direct evidence that attention-deficit/hyperactivity disorder is a genetic disorder and say their research could eventually lead to better treatments for the condition.
Researchers who scanned the gene maps of more...

More than 100,000 bottles of PediaCare products have been recalled by Blacksmith Brands, Inc., in consultation with the U.S. Food and Drug Administration, because they were made at at McNeil's Fort Washington plant.
The company is voluntarily recalling...

Although first approved to treat schizophrenia, new antipsychotic medications are increasingly being prescribed for a host of other uses, even when there is little evidence they work, U.S. researchers said on Friday.
The drugs, known as "atypical...

This year is shaping up as a gratifying one for Allergan, the big Irvine company known for Botox and breast implants.
The leading manufacturer of gastric bands, which are surgically implanted around the stomach to suppress the appetite of extremely...